We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Release of Debt and Directorate Change

14 Apr 2023 07:00

RNS Number : 1918W
Non-Standard Finance PLC
14 April 2023
 

Non-Standard Finance plc

('Non-Standard Finance', 'NSF' or the 'Company')

Update on Proposed Recapitalisation: Proposed Release of Debt and Directorate Change

14 April 2023: Further to its announcement dated 17 March 2023 regarding the launch of the Scheme and Proposed Recapitalisation, Non-Standard Finance announces that it has agreed with its secured lenders (the "Lenders") the provisional terms of a release of debt through a conversion into equity, as part of the Proposed Recapitalisation which is conditional on the successful completion of the Scheme.

In connection with the Proposed Recapitalisation, the Lenders have provisionally agreed, subject to finalising detailed terms and formalising requisite documentation, to release £71 million of secured debt in exchange for new ordinary shares in NSF. As a result, it is anticipated the Lenders would hold approximately 20% of NSF's enlarged issued share capital if the proposed capital raise is successful. As at 31 December 2022, the Company had total gross debt of £255 million. 

As previously announced, the Proposed Recapitalisation also involves the maturity date under the Group's secured debt facilities being extended from August 2023 to June 2027. In addition, the facilities are expected to be amended to have a reduced fixed interest rate of 5% with an additional payment in kind element of 3% in 2025 and 4% from 2026 onwards, payable at maturity. 

The Board welcomes the indicative proposal from its Lenders which would substantially improve the Company's balance sheet following a successful capital raise, underpinning the prospects for strong growth in NSF's ongoing branch-branched lending business and a return to Group profitability.

Further to its announcement dated 13 February 2023, trading in the Group's remaining operating division, Everyday Loans (branch-based lending) which sits under Everyday Lending Limited ("ELL"), remains encouraging. The full year 2022 audit is underway and results will be announced later in April. The following figures are therefore all unaudited. As previously reported, ELL's net loan book grew 6.2% during the year to £167m as at 31st December 2022, driven by a c20% increase in lending. Revenue grew broadly in line with the loan book. Customer numbers increased slightly year-on-year to 66,500. The collections performance of the business remains ahead of expectation and delinquency performance has returned to historically normal levels. The nature of IFRS 9 accounting means that the increase in lending has led to a corresponding increase in impairment, alongside a further macroeconomic overlay increase to reflect the anticipated future impact of the cost of living crisis. As a result, impairment rates are gradually seeing a reversal of the recent low levels, though remain below expectations.

Although the Proposed Recapitalisation will ensure the future of the Group and the Everyday Loans business, it will materially dilute the interests of NSF's existing equity holders, most likely to negligible value, unless they choose to participate in the equity raise.

The Group reminds Shareholders that if the Scheme is sanctioned but the Proposed Recapitalisation is unsuccessful, then the Alternative Transaction will be pursued involving a transfer of the ownership of the Group's business to the Lenders in exchange for the release of a portion of their secured debt and the provision of a new lending facility, resulting in no return for current shareholders. In the event that the Scheme is not sanctioned by the Court, or the Scheme is sanctioned but the Proposed Recapitalisation and Alternative Transaction both fail, then the Group would remain insolvent and the most likely outcome would be a Group-wide insolvency (most likely administration), also resulting in no return for current shareholders.

Directorate Change

Non-Standard Finance announces that, having served on the Board for over 8 years, non-executive chairman Charles Gregson has decided not to stand for re-election at the Company's 2023 Annual General Meeting (the "AGM"). Charles will stand down from the Board following the AGM. At the AGM, Niall Booker will stand for election as non-executive chairman to replace Charles.

Unless otherwise defined, capitalised terms within this announcement shall have the same meaning as those contained within the Company's announcement dated 17 March 2023, released at 7:39 am under RNS number 3475T.

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging the release of this announcement on behalf of Non-Standard Finance plc is Sarah Day, Chief ESG Officer and Group Company Secretary.

For more information:

 

Non-Standard Finance plc

Jono Gillespie, Group Chief Executive Officer

Sarah Day, Chief ESG Officer and Company Secretary

+44 203 869 9020

Cenkos Securities plc 

Nicholas Wells

Ben Jeynes

Callum Davidson

+44 207 397 8900

H/Advisors Maitland

+44 207 379 5151

Neil Bennett

+44 7900 000777

Finlay Donaldson

+44 7341 788066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFDESDEDSEDL
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.